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GENERIC-NAME PRESCRIPTION AND PERCEIVED QUALITY
IN THE DEMAND FOR PHARMACEUTICALS IN ARGENTINA
Maceira DA, Kurtzbart R
Center for the Study of the State and Society, Buenos Aires,
Argentina
OBJECTIVES: Pharmaceutical markets are examples of imper-
fect competition, based on product differentiation associated to
perceive quality under a patent scheme. In Argentina, the 25649
law in 2002 deﬁned the “duty to prescribe medicines by the
generic name of their active principle”, changing the prior nor-
mative that allow brand names in prescriptions. The aim of the
initiative was to provide the opportunity for substitution based
on prices of products therapeutically equivalent, triggering price
reductions and higher access to pharmaceuticals. Considering
pharmaceutical markets as an array of sub-markets with non-
homogeneous characteristics, this paper focuses on the analysis
of two therapeutic classes: hypolipemiants and calcium blockers.
The objective is to measure the impact of the normative on
prices, by using a data set of monthly sales by ﬁrm and by brand
for the period July 1999–June 2004. METHODS: By using a dis-
crete choice model of product differentiation, the econometric
implementation shows a panel data analysis where each ﬁrm’s
market share is explained by price and non-price characteristics,
plus a dummy variable that account for normative switch, cor-
rected by macroeconomic variables (exchange rates and eco-
nomic activity ﬂuctuations). Among non-market characteristics,
the estimations consider age of the product as a proxy or repu-
tation builder, manufacturer position in the local market, and
nature of the capital (local or multinational ﬁrm). RESULTS:
Results show that product age is signiﬁcant and positive expla-
nation for market share in both classes studied, while foreign
capital and industry leadership have the expected sign just for
one of the markets considered. Additionally, price is negative and
signiﬁcant at 99%. CONCLUSION: However, price sensitivity
to the price increased only about 0.9% and 0.3% for each
market because of the normative change, which shows perceived
quality as the main explanation for demand, and rejecting the
hypothesis of truncated demand function based on loyalty.
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RACIAL/ETHNIC DISPARITIES IN PRESCRIPTION DRUG
UTILIZATION AND OUT-OF-POCKET COSTS
Bhandari A
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OBJECTIVES: There is very limited existing research on
national-level racial/ethnic disparities in overall prescription
drug utilization and out-of-pocket prescription drug (OOP PD)
expenditures in working-age adults. This analysis used the 2002
Medical Expenditure Panel Survey (MEPS) to study pharma-
ceutical use and OOP PD expenditure differences across racial/
ethnic groups, in a nationally representative population of Asian,
Black, Hispanic and White adults age 18–64. METHODS: The
predisposing, enabling, and need framework of the Andersen
Behavioral Model of Health Services Utilization was used to
guide hypotheses and variable selection. MEPS is a national
survey of health care use, expenditures, sources of payment, and
insurance coverage. A negative binomial regression model was
used to analyze the number of annual prescriptions and a two-
part model was used to model annual OOP PD expenditures.
These models adjusted for various demographic, health status,
income and insurance coverage variables. RESULTS: In unad-
justed analyses, Whites ﬁlled an average of 10.1 medicines in
2002; this was signiﬁcantly greater than drug use for Hispanics
(4.72), Blacks (8.55) and Asians (4.1), p-value < 0.05 for all com-
parisons. After adjusting for predisposing, enabling and need
factors, statistically signiﬁcant differences in levels of medication
use across racial/ethnic groups remained: compared to Whites,
Asians used 47.8%, Blacks 26.2% and Hispanics 39.1%, fewer
prescription drugs per year. In unadjusted analyses, Whites had
OOP costs of $218, compared to $110, $163, and $75 for His-
panics, Blacks, and Asians, respectively. After adjustment, among
subjects with any drug expenditures, these racial/ethnic groups
had 38%, 30% and 56% lower expenditures compared to
Whites, respectively. CONCLUSION: This study found signi-
ﬁcant disparities in pharmaceutical use across racial/ethnic
groups, even after controlling factors such as income, insurance
coverage and health status. Pharmaceutical therapy is critical to
health care and lower utilization among minorities may explain
why these groups suffer disproportionately from the effects of
chronic diseases.
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THE IMPACT OF MAIL ORDER PHARMACY IN DRUG
UTILIZATION AND REIMBURSEMENT IN A LARGE
RETIREMENT SYSTEM
Seoane-Vazquez E, Rodriguez-Monguio R, Visaria J
Ohio State University, Columbus, OH, USA
OBJECTIVES: The objective of this study was to compare drug
utilization and drug net reimbursement for a retiree patient pop-
ulation using mail order pharmacy services with the results of a
model simulating the effect of community pharmacy services for
the same population. METHODS: The data source was a large
public employees’ retirement system pharmacy claims data for
the period January 2000–September 2005. The unit of analysis
was the course of drug therapy (CDT), representing the combi-
nation of unique patient ID, and unique. A retrospective cohort
study was comparing utilization and reimbursement patterns in
community vs. mail order pharmacy. A simulation model was
employed to assess drug utilization and reimbursement in com-
munity pharmacy using mail order pharmacy claim data. Drug
claims were aggregated to obtain a set of courses of drug therapy
(CDTs) representing unique patient IDs and unique drug name,
formulation, and strength. The model assumed that CDT in com-
munity pharmacy would have utilization patterns similar to
those found in mail order pharmacy. RESULTS: A total of
796,859 CDTs for 138,654 patients were included in the study.
Patients had an average of 6.7 CDTs, with 11.4 claims per CDT
and an average of 2.5 years in therapy. The study found high
drug therapy discontinuation ratios, with 78.1% of all CDTs dis-
continued during the study period. The use of mail order was
estimated to result in an increase of 3.4% in drug utilization in
comparison with community pharmacy. The effect of mail order
pharmacy on utilization varied by drug and by therapeutic class.
CONCLUSION: Mail order pharmacy increases drug utiliza-
tion. Pharmacy beneﬁt managers should implement programs to
identify and manage patients, diseases and drug therapies with
high therapy discontinuation. Decision makers should carefully
evaluate the utilization and cost effects that result from the
implementation of mail order pharmacy programs.
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